Viewing Study NCT05791695

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:02 PM
Ignite Modification Date: 2026-01-24 @ 5:43 PM
Study NCT ID: NCT05791695
Status: COMPLETED
Last Update Posted: 2023-12-01
First Post: 2023-02-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of the Incidence of Intraocular Inflammation and Suspected Endophthalmitis Among Patients Treated With Aflibercept, Vial and Pre-filled Syringe, 2014-2022
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intraocular Inflammation View
None Suspected Endophthalmitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Age-related macular degeneration View
None Anti-vascular endothelial growth factor View
None Diabetic macular edema View
None Diabetic retinopathy View
None Endophthalmitis View
None Intraocular inflammation View
None Retinal vein occlusion View
None Vascular endothelial growth factor View